Sign In
to Vote &
Create Storyboards.
 
Researchers at Rutgers, the State University of New Jersey, have used a targeted nanomedicine approach to deliver small molecule drugs and successfully treat mice with deadly advanced-stage ovarian cancer.Writing about their work in a recent print issue of the journal Clinical Cancer Research, the team explains how an out-of-control protein called CD44 aids tumor growth and development of drug resistance in advanced-stage ovarian cancer.Ovarian cancer is the deadliest gynecological cancer in the...
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard